BI
Bioelectronics Corporation
BIEL · OTC
$0.00 +0.00% (+$0.00)
1M -14.29%
Market Cap $7.41M
P/E Ratio -
Div. Yield -
ROE -
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 14.94x
P/E N/A
P/FFO N/A
Growth
0 /100
Declining Rev. growth 32.45%
EPS growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Gross margin 73.32%
FCF margin 33.09%
Net margin 187.62%
Quality
79 /100
Excellent ROIC 20.93%
Asset turnover 11.45x
ROA 2,148.02%
Debt
0 /100
High Current ratio 0.01x
Int. coverage -0.73x
Debt/Equity N/A
Stability
15 /100
Unstable Beta 2.02x
Profitable years 0
Rev. volatility 28.59%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BIEL
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Kelly A. Whelan
Employees
9
Headquarters
Frederick